Introduction: Mac-2-binding protein glycosylation isomer (M2BPGi) is a novel biomarker for liver fibrosis, but little is known about its role in cirrhosis-associated clinical outcomes. This study aimed to investigate the predictive role of M2BPGi in cirrhosis-associated complications. Methods: One hundred and forty-nine cirrhotic patients were retrospectively enrolled. Patients were followed up for 1 year, and cirrhosis-associated clinical events were recorded. Receiver operating characteristic curve (ROC) analysis was used to establish the values of the predictive models for cirrhotic outcomes, and Cox proportional hazards regression models were used to identify predictors of clinical outcomes. Results: Sixty (40.3%) patients experienced cirrhosis-associated clinical events and had higher M2BPGi levels compared to those without events (8.7 vs. 5.1 cutoff index, p < 0.001). The most common cirrhosis-associated complications were bacterial infections (24.2%). On ROC analysis, M2BPGi to albumin ratio (M2BPGi/albumin) had comparable discriminant abilities for all cirrhosis-associated events (area under the ROC curve [AUC] = 0.74) compared with M2BPGi, Child-Pugh, model for end-stage liver disease, albumin-bilirubin scores, and neutrophil-to-lymphocyte ratio and was superior to M2BPGi alone for all bacterial infectious events (AUC = 0.80). Cox regression analysis revealed that the M2BPGi/albumin, but not M2BPGi alone, independently predicted all cirrhosis-associated events (hazard ratio [HR] = 1.34, p = 0.038) and all bacterial infectious events (HR = 1.51, p = 0.011) within 1 year. However, M2BPGi/albumin did not predict other cirrhotic complications and transplant-free survival. Discussion/Conclusion: M2BPGi/albumin might serve as a potential prognostic indicator for patients with cirrhosis, particularly for predicting bacterial infections.

1.
Ginès
P
,
Krag
A
,
Abraldes
JG
,
Solà
E
,
Fabrellas
N
,
Kamath
PS
.
Liver cirrhosis
.
Lancet
.
2021
;
398
(
10308
):
1359
76
. .
2.
Liu
YB
,
Chen
MK
.
Epidemiology of liver cirrhosis and associated complications: current knowledge and future directions
.
World J Gastroenterol
.
2022
;
28
(
41
):
5910
30
. .
3.
D'Amico
G
,
Garcia-Tsao
G
,
Pagliaro
L
.
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies
.
J Hepatol
.
2006
;
44
(
1
):
217
31
. .
4.
Díaz-Hernández
HA
,
Vázquez-Anaya
G
,
Miranda-Zazueta
G
,
Castro-Narro
GE
.
The impact of different infectious complications on mortality of hospitalized patients with liver cirrhosis
.
Ann Hepatol
.
2020
;
19
(
4
):
427
36
. .
5.
Ripoll
C
,
Groszmann
R
,
Garcia-Tsao
G
,
Grace
N
,
Burroughs
A
,
Planas
R
, et al
.
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis
.
Gastroenterology
.
2007
;
133
(
2
):
481
8
. .
6.
Toyoda
H
,
Lai
PB
,
O’Beirne
J
,
Chong
CC
,
Berhane
S
,
Reeves
H
, et al
.
Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade
.
Br J Cancer
.
2016
;
114
(
7
):
744
50
. .
7.
Johnson
PJ
,
Berhane
S
,
Kagebayashi
C
,
Satomura
S
,
Teng
M
,
Reeves
HL
, et al
.
Assessment of liver function in patients with hepatocell.ular carcinoma: a new evidence-based approach-the ALBI grade
.
J Clin Oncol
.
2015
;
33
(
6
):
550
8
. .
8.
Sakamaki
A
,
Takamura
M
,
Sakai
N
,
Watanabe
Y
,
Arao
Y
,
Kimura
N
, et al
.
Longitudinal increase in albumin-bilirubin score is associated with non-malignancy-related mortality and quality of life in patients with liver cirrhosis
.
PLoS One
.
2022
;
17
(
2
):
e0263464
. .
9.
Chen
RC
,
Cai
YJ
,
Wu
JM
,
Wang
XD
,
Song
M
,
Wang
YQ
, et al
.
Usefulness of albumin-bilirubin grade for evaluation of long-term prognosis for hepatitis B-related cirrhosis
.
J Viral Hepat
.
2017
;
24
(
3
):
238
45
. .
10.
Biyik
M
,
Ucar
R
,
Solak
Y
,
Gungor
G
,
Polat
I
,
Gaipov
A
, et al
.
Blood neutrophil-to-lymphocyte ratio independently predicts survival in patients with liver cirrhosis
.
Eur J Gastroenterol Hepatol
.
2013
;
25
(
4
):
435
41
. .
11.
Rice
J
,
Dodge
JL
,
Bambha
KM
,
Bajaj
JS
,
Reddy
KR
,
Gralla
J
, et al
.
Neutrophil-to-Lymphocyte ratio associates independently with mortality in hospitalized patients with cirrhosis
.
Clin Gastroenterol Hepatol
.
2018
;
16
(
11
):
1786
91.e1
. .
12.
Magalhães
RDS
,
Magalhães
J
,
Sousa-Pinto
B
,
Cúrdia Gonçalves
T
,
Rosa
B
,
Cotter
J
.
Neutrophil-to-lymphocyte ratio: an accurate method for diagnosing infection in cirrhosis
.
Postgrad Med
.
2021
;
133
(
6
):
613
8
. .
13.
Shirabe
K
,
Bekki
Y
,
Gantumur
D
,
Araki
K
,
Ishii
N
,
Kuno
A
, et al
.
Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis
.
J Gastroenterol
.
2018
;
53
(
7
):
819
26
. .
14.
Hsu
YC
,
Jun
T
,
Huang
YT
,
Yeh
ML
,
Lee
CL
,
Ogawa
S
, et al
.
Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B
.
Aliment Pharmacol Ther
.
2018
;
48
(
10
):
1128
37
. .
15.
Su
TH
,
Peng
CY
,
Tseng
TC
,
Yang
HC
,
Liu
CJ
,
Liu
CH
, et al
.
Serum mac-2-binding protein glycosylation isomer at virological remission predicts hepatocellular carcinoma and death in chronic hepatitis B-related cirrhosis
.
J Infect Dis
.
2020
;
221
(
4
):
589
97
. .
16.
Hayashi
T
,
Tamaki
N
,
Kurosaki
M
,
Wang
W
,
Okada
M
,
Higuchi
M
, et al
.
Use of the serum wisteria floribunda agglutinin-positive Mac2 binding protein as a marker of gastroesophageal varices and liver-related events in chronic hepatitis C patients
.
Diagnostics
.
2020
;
10
(
3
):
173
. .
17.
Kikukawa
K
,
Uchida-Kobayashi
S
,
Tamori
A
,
Yoshida
K
,
Kotani
K
,
Motoyama
H
, et al
.
Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients
.
Ann Hepatol
.
2020
;
19
(
4
):
367
72
. .
18.
Hanai
T
,
Shiraki
M
,
Ohnishi
S
,
Miyazaki
T
,
Ideta
T
,
Kochi
T
, et al
.
Impact of serum glycosylated Wisteria floribunda agglutinin positive Mac-2 binding protein levels on liver functional reserves and mortality in patients with liver cirrhosis
.
Hepatol Res
.
2015
;
45
(
11
):
1083
90
. .
19.
Wu
PS
,
Hsieh
YC
,
Lee
KC
,
Huang
YH
,
Hou
MC
,
Lin
HC
.
Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients
.
PLoS One
.
2021
;
16
(
10
):
e0258589
. .
20.
Caironi
P
,
Gattinoni
L
.
The clinical use of albumin: the point of view of a specialist in intensive care
.
Blood Transfus
.
2009
;
7
(
4
):
259
67
. .
21.
Hariri
G
,
Joffre
J
,
Deryckere
S
,
Bigé
N
,
Dumas
G
,
Baudel
JL
, et al
.
Albumin infusion improves endothelial function in septic shock patients: a pilot study
.
Intensive Care Med
.
2018
;
44
(
5
):
669
71
. .
22.
Garcia-Martinez
R
,
Caraceni
P
,
Bernardi
M
,
Gines
P
,
Arroyo
V
,
Jalan
R
.
Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications
.
Hepatology
.
2013
;
58
(
5
):
1836
46
. .
23.
Alcaraz-Quiles
J
,
Casulleras
M
,
Oettl
K
,
Titos
E
,
Flores-Costa
R
,
Duran-Güell
M
, et al
.
Oxidized albumin triggers a cytokine storm in leukocytes through P38 mitogen-activated protein kinase: role in systemic inflammation in decompensated cirrhosis
.
Hepatology
.
2018
;
68
(
5
):
1937
52
. .
24.
Castera
L
,
Forns
X
,
Alberti
A
.
Non-invasive evaluation of liver fibrosis using transient elastography
.
J Hepatol
.
2008
;
48
(
5
):
835
47
. .
25.
Schuppan
D
,
Afdhal
NH
.
Liver cirrhosis
.
Lancet
.
2008
;
371
(
9615
):
838
51
. .
26.
Castéra
L
,
Vergniol
J
,
Foucher
J
,
Le Bail
B
,
Chanteloup
E
,
Haaser
M
, et al
.
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C
.
Gastroenterology
.
2005
;
128
(
2
):
343
50
. .
27.
Heinze
G
,
Wallisch
C
,
Dunkler
D
.
Variable selection: a review and recommendations for the practicing statistician
.
Biom J
.
2018
;
60
(
3
):
431
49
. .
28.
Huo
TI
,
Lin
HC
,
Lee
FY
,
Hou
MC
,
Lee
PC
,
Wu
JC
, et al
.
Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score
.
Liver Int
.
2006
;
26
(
1
):
55
61
. .
29.
Kamath
PS
,
Wiesner
RH
,
Malinchoc
M
,
Kremers
W
,
Therneau
TM
,
Kosberg
CL
, et al
.
A model to predict survival in patients with end-stage liver disease
.
Hepatology
.
2001
;
33
(
2
):
464
70
. .
30.
Schepke
M
,
Roth
F
,
Fimmers
R
,
Brensing
KA
,
Sudhop
T
,
Schild
HH
, et al
.
Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting
.
Am J Gastroenterol
.
2003
;
98
(
5
):
1167
74
. .
31.
Angermayr
B
,
Cejna
M
,
Karnel
F
,
Gschwantler
M
,
Koenig
F
,
Pidlich
J
, et al
.
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt
.
Gut
.
2003
;
52
(
6
):
879
85
. .
32.
Wedd
J
,
Bambha
KM
,
Stotts
M
,
Laskey
H
,
Colmenero
J
,
Gralla
J
, et al
.
Stage of cirrhosis predicts the risk of liver-related death in patients with low Model for End-Stage Liver Disease scores and cirrhosis awaiting liver transplantation
.
Liver Transpl
.
2014
;
20
(
10
):
1193
201
. .
33.
Heuman
DM
,
Abou-Assi
SG
,
Habib
A
,
Williams
LM
,
Stravitz
RT
,
Sanyal
AJ
, et al
.
Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death
.
Hepatology
.
2004
;
40
(
4
):
802
10
. .
34.
Kalra
A
,
Wedd
JP
,
Bambha
KM
,
Gralla
J
,
Golden-Mason
L
,
Collins
C
, et al
.
Neutrophil-to-lymphocyte ratio correlates with proinflammatory neutrophils and predicts death in low model for end-stage liver disease patients with cirrhosis
.
Liver Transpl
.
2017
;
23
(
2
):
155
65
. .
35.
Angkananard
T
,
Anothaisintawee
T
,
McEvoy
M
,
Attia
J
,
Thakkinstian
A
.
Neutrophil lymphocyte ratio and cardiovascular disease risk: a systematic review and meta-analysis
.
BioMed Res Int
.
2018
;
2018
:
2703518
. .
36.
Shiny
A
,
Bibin
YS
,
Shanthirani
CS
,
Regin
BS
,
Anjana
RM
,
Balasubramanyam
M
, et al
.
Association of neutrophil-lymphocyte ratio with glucose intolerance: an indicator of systemic inflammation in patients with type 2 diabetes
.
Diabetes Technol Ther
.
2014
;
16
(
8
):
524
30
. .
37.
Karakonstantis
S
,
Lydakis
C
.
Neutrophil-to-Lymphocyte ratio; an independent predictor of mortality or just a surrogate marker of underlying complications
.
Clin Gastroenterol Hepatol
.
2019
;
17
(
3
):
574
. .
38.
Hasegawa
K
,
Takata
R
,
Nishikawa
H
,
Enomoto
H
,
Ishii
A
,
Iwata
Y
, et al
.
Impact of wisteria floribunda agglutinin-positive mac-2-binding protein in patients with hepatitis C virus-related compensated liver cirrhosis
.
Int J Mol Sci
.
2016
;
17
(
9
):
1500
. .
39.
Xu
WP
,
Wang
ZR
,
Zou
X
,
Zhao
C
,
Wang
R
,
Shi
PM
, et al
.
Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein evaluates liver function and predicts prognosis in liver cirrhosis
.
J Dig Dis
.
2018
;
19
(
4
):
242
53
. .
40.
Byl
B
,
Roucloux
I
,
Crusiaux
A
,
Dupont
E
,
Devière
J
.
Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients
.
Gastroenterology
.
1993
;
104
(
5
):
1492
7
. .
41.
Hellstern
S
,
Sasaki
T
,
Fauser
C
,
Lustig
A
,
Timpl
R
,
Engel
J
.
Functional studies on recombinant domains of Mac-2-binding protein
.
J Biol Chem
.
2002
;
277
(
18
):
15690
6
. .
42.
Wiedermann
CJ
.
Hypoalbuminemia as surrogate and culprit of infections
.
Int J Mol Sci
.
2021
;
22
(
9
):
4496
. .
43.
Utariani
A
,
Rahardjo
E
,
Perdanakusuma
DS
.
Effects of albumin infusion on serum levels of albumin, proinflammatory cytokines (TNF-α, IL-1, and IL-6), CRP, and MMP-8; tissue expression of EGRF, ERK1, ERK2, TGF-β, collagen, and MMP-8; and wound healing in sprague dawley rats
.
Int J Inflam
.
2020
;
2020
:
3254017
. .
44.
Fernández
J
,
Clària
J
,
Amorós
A
,
Aguilar
F
,
Castro
M
,
Casulleras
M
, et al
.
Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis
.
Gastroenterology
.
2019
;
157
(
1
):
149
62
. .
45.
Di Pascoli
M
,
Fasolato
S
,
Piano
S
,
Bolognesi
M
,
Angeli
P
.
Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites
.
Liver Int
.
2019
;
39
(
1
):
98
105
. .
46.
Caraceni
P
,
Riggio
O
,
Angeli
P
,
Alessandria
C
,
Neri
S
,
Foschi
FG
, et al
.
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
.
Lancet
.
2018
;
391
(
10138
):
2417
29
. .
You do not currently have access to this content.